Osmotica Pharmaceuticals plc (OSMT) Prices 5M Share Common Offering at $6.55/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Osmotica Announces Pricing of Public Offering of Ordinary Shares
July 13, 2020 9:53 PM EDTBRIDGEWATER, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (Osmotica or the Company), a fully integrated biopharmaceutical company, announced today the pricing of its previously announced public offering of 5,000,000 ordinary shares at a price to the public of $6.55 per share. All of the shares are being offered by Osmotica. Osmotica also is granting the underwriters a 30-day option to purchase up to an additional 750,000 ordinary shares. The offering is expected to close on July 16, 2020, subject to satisfaction of customary closing conditions.
Credit Suisse Securities (USA) LLC is acting as... More
